Seeking Alpha

Theravance (THRX +2.4%) and GlaxoSmithKline (GSK +0.6%) have submitted a New Drug Application...

Theravance (THRX +2.4%) and GlaxoSmithKline (GSK +0.6%) have submitted a New Drug Application for the investigational drug UMEC/VI (LAMA/LABA), named Anoro Ellipta, which is a potential treatment for patients with chronic obstructive pulmonary disease. The companies also intend to file regulatory applications in the European Union as well as other countries in the coming year.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)